β-glucuronidase inhibitory studies on coumarin derivatives

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Enzyme Inhibition

Background:

• Beta-glucuronidase is a key enzyme in various biological processes.
• Coumarin derivatives are known for diverse pharmacological activities.
• Inhibitors of beta-glucuronidase have therapeutic potential.

Purpose of the Study:

• To synthesize novel coumarin derivatives.
• To evaluate the in vitro inhibitory activity of these derivatives against E. coli beta-glucuronidase.
• To establish a structure-activity relationship for coumarin-based beta-glucuronidase inhibitors.

Main Methods:

• Synthesis of 23 coumarin derivatives (compounds 5-27).
• In vitro enzyme inhibition assay using E. coli beta-glucuronidase.
• Determination of IC50 values for active compounds and the standard inhibitor (D-saccharic acid 1,4-lactone).

Main Results:

• Three coumarin derivatives (compounds 9, 18, and 15) exhibited inhibitory activity against beta-glucuronidase.
• Compound 9 (7,8-dihydroxy-4-methyl-2H-chromen-2-one) showed an IC50 of 52.39 ± 1.85 µM.
• Compound 18 (3-chloro-6-hexyl-7-hydroxy-4-methyl-2H-chromen-2-one) had an IC50 of 60.50 ± 0.87 µM.
• Compound 15 (3,6-dichloro-7-hydroxy-4-methyl-2H-chromen-2-one) displayed an IC50 of 380.26 ± 0.92 µM.
• The standard inhibitor, D-saccharic acid 1,4-lactone, had an IC50 of 45.75 ± 2.16 µM.

Conclusions:

• The synthesized coumarin derivatives show potential as inhibitors of E. coli beta-glucuronidase.
• The inhibitory activity is dependent on the specific substituents present on the coumarin scaffold.
• Further investigation into structure-activity relationships could lead to the development of more potent inhibitors.